Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.08 USD | +1.30% | +1.71% | +18.32% |
May. 29 | Declaration of Voting Results by National Health Investors | CI |
May. 09 | Land & Buildings Investment Management Comments on National Health Investors? Supplemental Proxy Statement | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is one of the best yield companies with high dividend expectations.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company benefits from high valuations in earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+18.32% | 2.87B | C- | ||
+14.97% | 61.99B | A- | ||
+0.51% | 14.01B | A | ||
+5.45% | 7.99B | B | ||
-5.80% | 6.14B | B- | ||
+14.32% | 3.63B | C- | ||
+2.24% | 3.38B | C+ | ||
+9.16% | 3.22B | C | ||
-6.13% | 3.08B | B+ | ||
-14.85% | 2.42B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NHI Stock
- Ratings National Health Investors, Inc.